openPR Logo
Press release

Investigation for Investors in Athenex, Inc. (NASDAQ: ATNX) over possible Violations of Securities Laws announced

06-02-2020 12:36 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Athenex, Inc. (NASDAQ: ATNX) shares over potential securities laws violations by Athenex, Inc.

An investigation for investors in Athenex, Inc. (NASDAQ: ATNX) shares over potential securities laws violations by Athenex, Inc.

Athenex, Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Athenex, Inc. (NASDAQ: ATNX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Athenex, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Buffalo, NY based Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions in North America and Asia.

In June 2017, Athenex, Inc. completed its initial public offering ("IPO"), issuing 6 million shares of common stock priced at $11.00 per share.

Athenex, Inc. reported that its annual Total Revenue rose from $89.1 million in 2018 to $101.22 million in 2019, and that its Net Loss increased from $117.44 million in 2018 to $123.74 million in 2019.

Then, on May 7, 2020, Athenex reported its financial and operating results for the first quarter of 2020. Among other results, the Company reported earnings per share that missed consensus estimates by $0.07.

Shares of Athenex, Inc. (NASDAQ: ATNX) declined on March 18, 2020, to as low as $5.63 per share.

Those who purchased shares of Athenex, Inc. (NASDAQ: ATNX) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Investors in Athenex, Inc. (NASDAQ: ATNX) over possible Violations of Securities Laws announced here

News-ID: 2064227 • Views: 452

More Releases from Shareholders Foundation

Investigation for Long-Term investors in NASDAQ: KNDI shares over possible Wrong …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Kandi Technologies Group Inc. Investors who are current long term investors in Kandi Technologies Group Inc (NASDAQ: KNDI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: KNDI stocks follows a lawsuit filed
Investigation for Long-Term Investors in shares of Kirby Corporation (NYSE: KEX) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Kirby Corporation. Investors who purchased shares of Kirby Corporation (NYSE: KEX) s have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Kirby Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders. Houston, TX based
Investigation announced for Investors in shares of Builders FirstSource, Inc. (N …
An investigation was announced concerning whether the takeover of Builders FirstSource, Inc. is unfair to NASDAQ: BLDR stockholders. Investors who purchased shares of Builders FirstSource, Inc. (NASDAQ: BLDR) and currently hold any of those NASDAQ: BLDR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Builders FirstSource, Inc. breached their
Investigation for Investors in ANSDAQ: ENDP over possible Wrongdoing at Endo Int …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Endo International plc. Investors who are current long term investors in Endo International plc (NASDAQ: ENDP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: ENDP stocks follows a lawsuit filed against Endo

All 5 Releases


More Releases for Athenex

Sodium Valproate Market 2019-2026 growing vigorously with top key players like s …
Up Market Research added a new Sodium Valproate Market research report for the period of 2019 – 2026. Report focuses on the major drivers and restraints providing analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. Get Sample Copy Of This Report @ https://www.upmarketresearch.com/home/requested_sample/88093 The report contains 95 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing
Sodium Valproate Market: Top Key Players Sanofi-aventis, AbbVie, Athenex, Fresen …
Sodium Valproate Market research report 2018-2023 presents a comprehensive study of the Sodium Valproate Market in Global Industry; the study scans the progression of the market trailed over the past few years and the forecasts of growth in the coming years, primarily in terms of sales. The research report highlights the reasons liable for the disparities in the market and investigates them methodically. The Sodium Valproate Market effect factors have
Spindle Cell Sarcoma Treatment Market Top Players: PharmaEngin, Morphotek, Thres …
Spindle Cell Sarcoma Treatment Market - Overview Global spindle cell sarcoma treatment market is expected to register a CAGR ~6.1% during the forecast period from 2018 to 2023. Spindle cell sarcoma is a rare malignant tumor which can be developed in bone or soft tissue. It can also occur in other body parts most commonly in limbs (arms and legs). There is no definite cause of this type of tumor, but this
Solar Keratosis Treatment Market Assessment – Latest Insights on Trends and Ch …
Latest research study from HTF MI with title Global Actinic by Manufacturers, Regions, Type and Application, Forecast to 2023. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data. The study is segmented by products type, application/end-users. The research study provides estimates for Global Actinic Forecast till 2023. If you are
Sodium Valproate Market: Leading Players – Sanofi-aventis, AbbVie, Athenex, Fr …
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures. Global Sodium Valproate Market report explores manufacturer’s competitive scenario and provides market share for all major players of this market based on production capacity, sales, revenue,
Actinic (Solar) Keratosis Treatment Industry Competitive Strategies 2025: Novart …
A new market assessment report on the Actinic (Solar) Keratosis Treatment market provides a comprehensive overview of the Actinic (Solar) Keratosis Treatment industry for the forecast period 2018 - 2025. The analytical study is proposed to provide immense clarity on the market size, share and growth rate across different regions. The profound knowledge and extensive examination of the trends from the yesteryear and future aims at offering the stakeholders,